SLC22A1 and hepatocellular carcinoma: In another study on Caucasian patients, OCT1 expression level was found to be significantly reduced in HCC but not in benign lesions, such as hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH) [78].